Dr Robert Preti | CEO & President
Hitachi Chemical Advanced Therapeutics Solutions, LLC

Dr Robert Preti, CEO & President, Hitachi Chemical Advanced Therapeutics Solutions, LLC

Robert “Bob” Preti is the co-founder and the visionary behind the successful growth and development strategy of PCT (on October 2, 2017 renamed Hitachi Chemical Advanced Therapeutics Solutions, LLC or “HCATS”) over much of the last two decades. Upon PCT’s acquisition by Hitachi Chemical Co., Ltd. in May 2017, Bob’s role expanded to General Manager, Regenerative Medicine Business Sector of Hitachi Chemical, responsible for development, management and oversight of the global business operations of Hitachi Chemical’s regenerative medicine business unit.  Bob built HCATS to meet a recognized need for high quality manufacturing and development services in an emerging industry. Bob is currently Chairman for the Alliance for Regenerative Medicine, where, among other activities, he previously served as Vice Chairman and in other roles. Bob holds a BS degree in biology from Fordham University, and a MS degree and Doctorate, both in biology, from New York University.

Appearances:



Advanced Therapies and Regenerative Medicine Day 1 - Wednesday 16th May 2018 @ 14:29

Chair:Robert Preti, Chief Executive Officer and President, Hitachi Chemical Advanvced Therapeutics Solutions, LLC

Advanced Therapies and Regenerative Medicine Day 1 - Wednesday 16th May 2018 @ 17:05

Panel discussion: how to approach automation for scaled-up manufacture of cell and gene therapies

Advanced Therapies and Regenerative Medicine Day 2 - Thursday 17th May 2018 @ 10:15

Are we asking the right questions to achieve deliverable advanced therapies? Lessons from the past and the challenges of the future

  •     An overview of almost forty years of cell therapeutics development
  •     Establishing the potential of cell-based therapies, enabling technologies and organizations
  •     Developing an applicable regulatory framework and guidance and a better appreciation of drug development principles
  •     Themes of the present and future as we advance deliverability of cell-based therapies

back to speakers

 

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com